Australia’s Applied Cannabis Research and MedReleaf Australia Launch Observational Patient Study – Releaf For VeteransPosted by On

Applied Cannabis Research, providing research expertise and services to medicinal cannabis companies

The Applied Cannabis Research and MedReleaf teams are proud to be supporting our Australian Veteran community

SYDNEY, NSW, AUSTRALIA, July 26, 2020 / — Applied Cannabis Research is pleased to announce that MedReleaf is planning to join the CA Clinics Observational study (CACOS) to explore the impact of medicinal cannabis on chronic pain in Veterans. The study is supported by MedReleaf Australia, which is committed to improving Veterans’ health, including through education and awareness about treatment options.

MedReleaf is excited to be engaged in this study involving Australia’s Veterans community, having already undertaken study programs with Veteran communities in Canada.

-Applied Cannabis Research plans to undertake a national observational study using MedReleaf products for Veterans

-Data will be collected from patients being prescribed MedReleaf products for management of their chronic pain, who have already exhausted conventional therapies.

-Study will recruit Veterans from across Australia through the nationwide medical chain CA Clinics*

-A previous study by MedReleaf on medical…

Original Author Link click here to read complete story..



Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.